Ai-len - Tiếng Anh - HPRA (Health Products Regulatory Authority)

concord pharmaceuticals ltd - sulfapyridine - tablets - 500 milligram

Canada - Tiếng Anh - Health Canada

pfizer canada ulc - sulfasalazine - tablet - 500mg - sulfasalazine 500mg - sulfonamides

Canada - Tiếng Anh - Health Canada

pfizer canada ulc - sulfasalazine - tablet (enteric-coated) - 500mg - sulfasalazine 500mg - sulfonamides

Canada - Tiếng Anh - Health Canada

pfizer canada ulc - sulfasalazine - enema - 3g - sulfasalazine 3g - sulfonamides

Canada - Tiếng Anh - Health Canada

pharmascience inc - sulfasalazine - tablet - 500mg - sulfasalazine 500mg - sulfonamides

Canada - Tiếng Anh - Health Canada

pharmascience inc - sulfasalazine - tablet (enteric-coated) - 500mg - sulfasalazine 500mg - sulfonamides

Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - sulfasalazine -

Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

sulfasalazine -

New Zealand - Tiếng Anh - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - sulfasalazine 500mg (sulfasalazine 500 mg added as 535 mg sulfasalazine with povidone) - tablet - 500 mg - active: sulfasalazine 500mg (sulfasalazine 500 mg added as 535 mg sulfasalazine with povidone) excipient: colloidal silicon dioxide magnesium stearate povidone pregelatinised maize starch - latest regulatory activity

New Zealand - Tiếng Anh - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - sulfasalazine 500mg (sulfasalazine 500 mg added as 535 mg sulfasalazine with povidone) - enteric coated tablet - 500 mg - active: sulfasalazine 500mg (sulfasalazine 500 mg added as 535 mg sulfasalazine with povidone) excipient: carnauba wax cellacefate colloidal silicon dioxide macrogol 20000 magnesium stearate povidone propylene glycol purified talc self-emulsifying glyceryl monostearate starch white beeswax - ulcerative colitis and crohn's disease adjunct in the treatment of ulcerative colitis with the usual supportive and dietary measures. for the management of severe, acute attacks of ulcerative colitis, rectal and systemic corticosteroid therapy appears to be clinically superior to sulfasalazine, but sulfasalazine may be more effective than corticosteroids in reducing the number of relapses in patients on maintenance therapy. in the treatment of active crohn's disease, especially in patients with colonic involvement. rheumatoid arthritis salazopyrin en tablets are indicated for rheumatoid arthritis which has failed to respond to nonsteroidal anti-inflammatory drugs (nsaids).